COR peers and competitors
Cencora, Inc. · end-of-day data as of Oct 16, 2026
Cencora, Inc.
$340.92+10.2%
Buy · 15 analystsPT $364.08 +6.8%
COR’s peers by industry and size include McKesson (MCK), Moderna (MRNA) and Regeneron Pharmaceuticals (REGN). Among these 12 companies COR ranks 5th by market cap ($65.06B); its P/E of 25.3 compares with a median of 30.5 for its peers.
Peers by industry and size
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $1,004.84 | +0.6% | 0.0% | -1.5% | 26.9 | $117B | |
| 2 |  | $218.01 | -7.8% | -7.8% | -25.0% | — | $87.04B | |
| 3 |  | $790.74 | -0.7% | -7.2% | +8.7% | 19.6 | $81.41B | |
| 4 |  | $302.30 | +1.2% | -0.2% | +10.9% | 12.5 | $79.88B | |
| 5 | | $340.92 | -0.1% | -8.5% | +6.8% | 25.3 | $65.06B | |
| 6 |  | $44.39 | +0.6% | -57.7% | +50.1% | 18.0 | $64.33B | |
| 7 |  | $254.06 | +0.1% | 0.0% | +4.5% | 35.1 | $58.83B | |
| 8 |  | $191.75 | -1.0% | -1.0% | -6.2% | 57.8 | $52.23B | |
| 9 |  | $86.60 | -1.7% | -9.0% | +15.2% | 49.8 | $49.9B | |
| 10 |  | $413.16 | -4.4% | -4.7% | +15.7% | 39.1 | $49.63B | |
| 11 |  | $172.97 | -1.5% | -1.5% | +0.5% | 34.0 | $48.77B | |
| 12 |  | $86.38 | -0.7% | -4.9% | +6.0% | 25.2 | $9.63B |
Data as of Oct 16, 2026 close.